Notal Vision names new CEO

Notal Vision CEO Quinton Oswald will step down from the post at the end of 2018, and Susan Orr, OD, the company’s current chief medical officer and vice president of medical affairs, has been appointed to the position, according to a press release.

Orr will take over as of Jan. 1, 2019.

Oswald will continue to serve on the company’s board of directors, and Grace Chang, MD, PhD, will become chief medical officer.

“Notal Vision is revolutionizing the field of home diagnostics for retinal disease, and I look forward to continuing our progress and further innovating as chief executive officer,” Orr said in the release. “I am honored to be following in the footsteps of Quinton Oswald, who has always sought out disruptive and innovative therapies and technology in the retina space.”

Notal Vision CEO Quinton Oswald will step down from the post at the end of 2018, and Susan Orr, OD, the company’s current chief medical officer and vice president of medical affairs, has been appointed to the position, according to a press release.

Orr will take over as of Jan. 1, 2019.

Oswald will continue to serve on the company’s board of directors, and Grace Chang, MD, PhD, will become chief medical officer.

“Notal Vision is revolutionizing the field of home diagnostics for retinal disease, and I look forward to continuing our progress and further innovating as chief executive officer,” Orr said in the release. “I am honored to be following in the footsteps of Quinton Oswald, who has always sought out disruptive and innovative therapies and technology in the retina space.”